BioSpace – FDA Commissioner Califf and the Potential of RWE in Clinical Trials
When Robert Califf became the new commissioner of the U.S. Food & Drug Administration, he did so with a plan to emphasize the use of real-world evidence (RWE) in Agency decisions. So, even though the FDA has been evaluating the use of RWE and issued draft guidance a few months ago, “There’s still quite a bit to do,”…